• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Positron delisted from NASDAQ

Article

PET manufacturer Positron continues to be dogged by cash-flow problems. On July 7, the Houston-based vendor was delisted from the NASDAQ stock exchange, due to noncompliance with NASDAQ's minimum capital and surplus requirements.Financial difficulties

PET manufacturer Positron continues to be dogged by cash-flow problems. On July 7, the Houston-based vendor was delisted from the NASDAQ stock exchange, due to noncompliance with NASDAQ's minimum capital and surplus requirements.

Financial difficulties were also cited by the vendor in its decision not to exhibit at the annual meeting of the Society of Nuclear Medicine meeting in June (SCAN 6/25/97). Earlier, a deal to buy the PET assets of GE Medical Systems collapsed as a result of difficulties in securing funds for the acquisition (SCAN 4/30/97).

Positron's stock will now be traded on the OTC bulletin board. The company intends to reapply for listing as soon it completes its recapitalization and meets the minimum listing requirements, said Gary Wood, chairman.

Recent Videos
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Related Content
© 2025 MJH Life Sciences

All rights reserved.